Anti-Parasitic Vaccines and Host Immune Responses
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 31 August 2026 | Viewed by 684
Editor
Interests: vaccines against influenza virus, respiratory syncytial virus, and parasites such as Plasmodium spp. (malaria), Leishmania donovani , Leishmania amazonensis , and Toxoplasma gondii; host immune responses induced by helminth infections with Trichinella spiralis or Clonorchis sinensis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Parasites pose a significant public health challenge as they are responsible for a wide range of diseases that have considerable global health and economic impacts, particularly in low-income countries. The challenge in developing vaccines against parasites stems from their ability to evade the host’s immune system and the complexity of their antigens. Therefore, further research is essential to prevent parasitic diseases. This Special Issue invites original research articles and review papers. Potential research topics include vaccine antigen design, vaccination strategies, vaccine delivery methods, vaccine efficacy studies, and host immune responses to parasite infections.
We look forward to receiving your contributions.
Prof. Dr. Fu-Shi Quan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- malaria
- Leishmania donovani
- Leishmania amazonensis
- Toxoplasma gondii
- Trichinella spiralis
- Clonorchis sinensis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
